Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

Clinical trial NCT03582124 · RECRUITING

Trial details

NCT number: NCT03582124
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Carcinoma Metastatic Malignant Neoplasm in the Lung Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2018-07-19
Primary completion: 2026-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.